Skip to main content
SpringerLink
Log in

Large-sized hepotocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT)

  • Interventional
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

This study aims to evaluate the efficacy and safety of a neoadjuvant treatment protocol with repeated transarterial chemoembolization (TACE) before MR-guided laser-induced thermotherapy (LITT) for large-sized hepatocellular carcinomas (HCC). Repeated TACE (mean, 3.5 treatments per patient) was performed in 48 patients with neoadjuvant intention (the largest lesion was between 50 and 80 mm in diameter, and there were no more than five lesions). For the TACE treatment, we used 10 mg/m2 mitomycin, 10 ml/m2 Lipiodol and microspheres. The tumor volume was measured by MRI. Lipiodol retention of the tumors was evaluated with CT. After the diameter of the tumors had decreased to less than 50 mm, the patients were treated with MR-guided LITT 4 to 6 weeks after embolization. Repeated TACE reduced the tumor size in 32 patients (66.7%), forming the basis for performing MR-guided LITT procedures. These patients received one to four laser treatments (mean, 1.9 per patient) for tumor ablation, resulting in a median survival of 36.0 months after the first treatment. For the remaining patients, no reduction in tumor size was achieved in 12 patients and disease progression in 4 patients. Neoadjuvant TACE appears to be an effective treatment of large-sized HCC, which extends the indication for MR-guided LITT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bruix J, Sala M, Llovet J (2004) Chemoembolization for hepatocellular carcinoma. Gastroenterology 127:S179–S188

    Article  PubMed  CAS  Google Scholar 

  2. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC (1997) Increase in primary liver cancer in the UK, 1979–94. Lancet 350:1142–1143

    Article  PubMed  CAS  Google Scholar 

  3. Llovet J, Sala M (2005) Non-surgical therapies of hepatocellular carcinoma (In Process Citation). Eur J Gastroenterol Hepatol 17:505–513

    Article  PubMed  Google Scholar 

  4. Bruix J, Sherman M, Llovet J et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver. J Hepatol 35:421–430

    Article  PubMed  CAS  Google Scholar 

  5. Livraghi T, Giorgio A, Marin G et al (1995) Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 197:101–108

    PubMed  CAS  Google Scholar 

  6. Ishii H, Okada S, Nose H et al (1996) Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection. Cancer 77:1792–1796

    Article  PubMed  CAS  Google Scholar 

  7. Vogl TJ, Straub R, Eichler K, Woitaschek D, Mack MG (2002) Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2,520 lesions). Radiology 225:367–377

    Article  PubMed  Google Scholar 

  8. Nikfarjam M, Christophi C (2003) Interstitial laser thermotherapy for liver tumours. Br J Surg 90:1033–1047

    Article  PubMed  CAS  Google Scholar 

  9. Midorikawa T, Kumada K, Kikuchi H et al (2000) Microwave coagulation therapy for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 7:252–259

    Article  PubMed  CAS  Google Scholar 

  10. Ishida T, Murakami T, Shibata T, Inoue Y, Takamura M, Niinobu T, Sato T, Nakamura H (2002) Percutaneous microwave tumor coagulation for hepatocellular carcinomas with interruption of segmental hepatic blood flow. J Vasc Interv Radiol 13:185–191

    Article  PubMed  Google Scholar 

  11. Allgaier HP, Deibert P, Zuber I, Olschewski M, Blum HE (1999) Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 353:1676–1677

    Article  PubMed  CAS  Google Scholar 

  12. Livraghi T (2003) Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 10:67–76

    PubMed  Google Scholar 

  13. Llovet J, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907–1917

    Article  PubMed  Google Scholar 

  14. Allgaier HP, Deibert P, Olschewski M, Spamer C, Blum U, Gerok W, Blum HE (1998) Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection—a single-center analysis including 132 patients. Int J Cancer 79:601–605

    Article  PubMed  CAS  Google Scholar 

  15. Vogl TJ, Trapp M, Schroeder H, Mack M, Schuster A, Schmitt J, Neuhaus P, Felix R (2000) Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 214:349–357

    PubMed  CAS  Google Scholar 

  16. Lee K, Sung K, Lee D, Park S, Kim K, Yu J (2002) Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. Radiographics 22:1077–1091

    PubMed  Google Scholar 

  17. Mondazzi L, Bottelli R, Brambilla G, Rampoldi A, Rezakovic I, Zavaglia C, Alberti A, Ideo G (1994) Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology 19:1115–1123

    Article  PubMed  CAS  Google Scholar 

  18. O’Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST (2003) Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg 90:325–331

    Article  PubMed  CAS  Google Scholar 

  19. Okazaki M, Yamasaki S, Ono H et al (1993) Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Hepatogastroenterology 40:320–323

    PubMed  CAS  Google Scholar 

  20. Fan J, Tang ZY, Yu YQ, Wu ZQ, Ma ZC, Zhou XD, Zhou J, Qiu SJ, Lu JZ (1998) Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. Dig Surg 15:674–678

    Article  PubMed  CAS  Google Scholar 

  21. Tellez C, Benson AB, 3rd, Lyster MT, Talamonti M, Shaw J, Braun MA, Nemcek AA Jr, Vogelzang RL (1998) Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82:1250–1259

    Article  PubMed  CAS  Google Scholar 

  22. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53:457–481

    Article  Google Scholar 

  23. Nagasue N, Kohno H, Chang YC et al (1993) Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 217:375–384

    Article  PubMed  CAS  Google Scholar 

  24. Mok KT, Wang BW, Lo GH et al (2003) Multimodality management of hepatocellular carcinoma larger than 10 cm. J Am Coll Surg 197:730–738

    Article  PubMed  Google Scholar 

  25. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232:381–391

    Article  PubMed  CAS  Google Scholar 

  26. Dwerryhouse SJ, Seifert JK, McCall JL, Iqbal J, Ross WB, Morris DL (1998) Hepatic resection with cryotherapy to involved or inadequate resection margin (edge freeze) for metastases from colorectal cancer. Br J Surg 85:185–187

    Article  PubMed  CAS  Google Scholar 

  27. Finlay IG, Seifert JK, Stewart GJ, Morris DL (2000) Resection with cryotherapy of colorectal hepatic metastases has the same survival as hepatic resection alone. Eur J Surg Oncol 26:199–202

    Article  PubMed  CAS  Google Scholar 

  28. Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240

    Article  PubMed  Google Scholar 

  29. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88:2452–2463

    Article  PubMed  CAS  Google Scholar 

  30. Verhoef C, Kuiper JW, Heisterkamp J, de Man RA, Pattynama PM, JN IJ (2003) Interstitial laser coagulation with temporary hepatic artery occlusion for patients with cirrhosis and irresectable hepatoma. Br J Surg 90:950–955

    Article  PubMed  CAS  Google Scholar 

  31. Curley SA, Izzo F (2002) Radiofrequency ablation of hepatocellular carcinoma. Minerva Chir 57:165–176

    PubMed  CAS  Google Scholar 

  32. Vogl TJ, Mack MG, Balzer JO, Engelmann K, Straub R, Eichler K, Woitaschek D, Zangos S (2003) Liver metastases: neoadjuvant downsizing with transarterial chemoembolization before laser-induced thermotherapy. Radiology 229:457–464

    Article  PubMed  Google Scholar 

  33. Wacker FK, Reither K, Ritz JP, Roggan A, Germer CT, Wolf KJ (2001) MR-guided interstitial laser-induced thermotherapy of hepatic metastasis combined with arterial blood flow reduction: technique and first clinical results in an open MR system. J Magn Reson Imaging 13:31–36

    Article  PubMed  CAS  Google Scholar 

  34. Whelan WM, Wyman DR, Wilson BC (1995) Investigations of large vessel cooling during interstitial laser heating. Med Phys 22:105–115

    Article  PubMed  CAS  Google Scholar 

  35. Matthewson K, Coleridge-Smith P, O’Sullivan JP, Northfield TC, Bown SG (1987) Biological effects of intrahepatic neodymium: yttrium-aluminum-garnet laser photocoagulation in rats. Gastroenterology 93:550–557

    PubMed  CAS  Google Scholar 

  36. Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47–54

    Article  PubMed  Google Scholar 

  37. Llovet J, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 37:429–442

    Article  PubMed  CAS  Google Scholar 

  38. Maataoui A, Qian J, Vossoughi D, Khan MF, Oppermann E, Bechstein WO, Vogl TJ (2005) Transarterial chemoembolization alone and in combination with other therapies: a comparative study in an animal HCC model. Eur Radiol 15:127–133

    Article  PubMed  CAS  Google Scholar 

  39. Tancredi T, McCuskey PA, Kan Z, Wallace S (1999) Changes in rat liver microcirculation after experimental hepatic arterial embolization: comparison of different embolic agents. Radiology 211:177–181

    PubMed  CAS  Google Scholar 

  40. Yoshioka H, Sato M, Sonomura T, Terada M, Kishi K, Yoshikawa A (1997) Factors associated with survival exceeding 5 years after transcatheter arterial embolization for hepatocellular carcinoma. Semin Oncol 24:S6–29–S26–37

    Google Scholar 

  41. Yamakado K, Nakatsuka A, Ohmori S, Shiraki K, Nakano T, Ikoma J, Adachi Y, Takeda K (2002) Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 13:1225–1232

    Article  PubMed  Google Scholar 

  42. Bartolozzi C, Lencioni R, Caramella D et al (1995) Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 197:812–818

    PubMed  CAS  Google Scholar 

  43. Lencioni R, Paolicchi A, Moretti M et al (1998) Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate. Eur Radiol 8:439–444

    Article  PubMed  CAS  Google Scholar 

  44. Rossi S, Garbagnati F, Lencioni R et al (2000) Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217:119–126

    PubMed  CAS  Google Scholar 

  45. Takamura M, Murakami T, Shibata T et al (2001) Microwave coagulation therapy with interruption of hepatic blood in-or outflow: an experimental study. J Vasc Interv Radiol 12:619–622

    Article  PubMed  CAS  Google Scholar 

  46. Trevisani F, De Notariis S, Rossi C, Bernardi M (2001) Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies? J Clin Gastroenterol 32:383–389

    Article  PubMed  CAS  Google Scholar 

  47. Albrecht D, Germer CT, Isbert C, Ritz JP, Roggan A, Muller G, Buhr HJ (1998) Interstitial laser coagulation: evaluation of the effect of normal liver blood perfusion and the application mode on lesion size. Lasers Surg Med 23:40–47

    Article  PubMed  CAS  Google Scholar 

  48. Heisterkamp J, van Hillegersberg R, Zondervan PE, JN IJ (1999) Long-term effects of interstitial laser coagulation in porcine liver with portal inflow occlusion: central versus peripheral lesions. J Vasc Interv Radiol 10:825–831

    Article  PubMed  CAS  Google Scholar 

  49. de Baere T, Bessoud B, Dromain C et al (2002) Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol 178:53–59

    PubMed  Google Scholar 

  50. Yamakado K, Nakatsuka A, Akeboshi M, Shiraki K, Nakano T, Takeda K (2004) Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival. Oncol Rep 11:105–109

    PubMed  Google Scholar 

  51. Pacella CM, Bizzarri G, Cecconi P, Caspani B, Magnolfi F, Bianchini A, Anelli V, Pacella S, Rossi Z (2001) Hepatocellular carcinoma: longterm results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 219:669–678

    PubMed  CAS  Google Scholar 

  52. Kim HK, Chung YH, Song BC et al (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32:423–427

    Article  PubMed  CAS  Google Scholar 

  53. Shah SR, Riordan SM, Karani J, Williams R (1998) Tumour ablation and hepatic decompensation rates in multi-agent chemoembolization of hepatocellular carcinoma. Qjm 91:821–828

    Article  PubMed  CAS  Google Scholar 

  54. Huppert PE, Lauchart W, Duda SH, Torkler C, Kloska SP, Weinlich M, Benda N, Pereira P, Claussen CD (2004) Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival? Rofo 176:375–385

    PubMed  CAS  Google Scholar 

  55. Vogl TJ, Mack M, Straub R, Eichler K, Engelmann K, Roggan A, Zangos S (2000) Percutaneous interstitial thermotherapy of malignant liver tumors. (Perkutane interstitielle Thermotherapie maligner Lebertumoren. ). Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 172:12–22

    Article  PubMed  CAS  Google Scholar 

  56. Bloomston M, Binitie O, Fraiji E et al (2002) Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 68:827–831

    PubMed  Google Scholar 

  57. Buscarini L, Buscarini E, Di Stasi M, Quaretti P, Zangrandi A (1999) Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 20:47–53

    Article  PubMed  CAS  Google Scholar 

  58. Takayasu K, Arii S, Matsuo N et al (2000) Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol. 175:699–704

    PubMed  CAS  Google Scholar 

  59. Guan YS, Sun L, Zhou XP, Li X, Zheng XH (2004) Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up. World J Gastroenterol. 10:3543–3548

    PubMed  Google Scholar 

  60. Chen CY, Li CW, Kuo YT, Jaw TS, Wu DK, Jao JC, Hsu JS, Liu GC (2006) Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants–initial experience. Radiology 28:28

    CAS  Google Scholar 

  61. Castrucci M, Sironi S, De Cobelli F, Salvioni M, Del Maschio A (1996) Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization. Abdom Imaging 21:488–494

    Article  PubMed  CAS  Google Scholar 

  62. Kim HC, Kim AY, Han JK, Chung JW, Lee JY, Park JH, Choi BI (2002) Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images. Radiology. 225:773–780

    Article  PubMed  Google Scholar 

  63. Kubota K, Hisa N, Nishikawa T, Fujiwara Y, Murata Y, Itoh S, Yoshida D, Yoshida S (2001) Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging 26:184–190

    Article  PubMed  CAS  Google Scholar 

  64. Abramson R, Rosen M, Perry L, Brophy D, Raeburn S, Stuart K (2000) Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Radiology 216:485–491

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic and Interventional Radiology, University Hospital Frankfurt, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, 60590, Frankfurt/Main, Germany

    Stephan Zangos, Katrin Eichler, Jörn O. Balzer, Ralf Straub, Renate Hammerstingl, Christopher Herzog, Thomas Lehnert, Mathias Heller, Axel Thalhammer, Martin G. Mack & Thomas J. Vogl

Authors
  1. Stephan Zangos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katrin Eichler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jörn O. Balzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ralf Straub
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Renate Hammerstingl
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christopher Herzog
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Thomas Lehnert
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mathias Heller
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Axel Thalhammer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Martin G. Mack
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Thomas J. Vogl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephan Zangos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zangos, S., Eichler, K., Balzer, J.O. et al. Large-sized hepotocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol 17, 553–563 (2007). https://doi.org/10.1007/s00330-006-0343-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-006-0343-x

Keywords

Search

Navigation